• Front Matter R1-R18

• Summary and Assessment 1-19

• 1 Introduction 20-42

• 2 Assessing Our Understanding of the Threats 43-84

• 3 Vaccines: Research, Development, Production, and Procurement Issues 85-112

• 4 The Research Agenda: Implications for Therapeutic Countermeasures to Biological Threats 113-147

• 5 Assessing the Capacity of the Public Health Infrastructure 148-181

• 6 Scientific and Policy Tools for Countering Bioterrorism 182-219

• Appendix A: Agenda: Biological Threats and Terrorism: How Preparted Are We? 220-224

• Appendix B: Information Resources 225-234

• Appendix C: Testimony of Joshua Lederberg, Ph.D. 235-238

• Appendix D: Summary of the Frist-Kennedy 239-243

• Appendix E: Department of Health and Human Services: Food and Drug Administration 244-251

• Appendix F: Veterans Affairs/Department of Defense Contingency 252-253

• Appendix G: The Model State Emergency Health Powers Act 254-256

• Appendix H: NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness 257-261

• Appendix I: Statement on Vaccine Development 262-268

• Appendix J: Testimony of Kenneth Shine, M.D. 269-274

• Appendix K: Glossary and Acronyms 275-286

• Appendix L: Forum Member, Speaker, and Staff Biographies 287-317

" Appendix C: Testimony of Joshua Lederberg, Ph.D. ." Biological Threats and Terrorism: Assessing the Science and Response Capabilities: Workshop Summary . Washington, DC: The National Academies Press, 2002 .

Please select a format: